Quinazolone-Alkyl-Carboxylic Acid Derivatives Inhibit Transmembrane Ca2+Ion Flux to (+)-(S)-α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid
- 1 April 2001
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 59 (4), 920-928
- https://doi.org/10.1124/mol.59.4.920
Abstract
Comparison of the kinetics of the inward Ca2+ ion flux to (S)-α-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid [(S)-AMPA] in cerebrocortical homogenates and that of the previously reported transmembrane Na+ ion influx mediated by an AMPA receptor in hippocampal homogenates established that the agonist-induced opening of the AMPA receptor channels occurs in two kinetically distinguishable phases. Here we report that the 2-methyl-4-oxo-3H-quinazoline-3-acetic acid (Q1) inhibits the major slow-phase response specifically, whereas the acetyl piperidine derivative (Q5) is a more potent inhibitor of the fast-phase response. Both the quinazolone-3-propionic acid (Q2) and the quinazolone-3-acetic acid methyl ester (Q3) enhanced the slow-phase response to (S)-AMPA. The information provided by docking different Q1, Q2, and Q5 models at the ligand-binding core of iGluRs were used to define agonistic and antagonistic modes of interactions. Based on the effects of quinazolone-3-alkyl-carboxylic acid derivatives on specific [3H]Glu binding and kinetically distinguishable Ca2+ ion permeability responses to (S)-AMPA and molecular modeling, the fast- and the slow-phase (S)-AMPA-elicited Ca2+ ion fluxes were corresponded to different subunit compositions and degrees of S1S2 bridging interaction relative to substitution of kainate thereupon. Substitutions of agonists and antagonists into the iGluR2 S1S2 ligand binding core induced different modes of domain-domain bridging.Keywords
This publication has 23 references indexed in Scilit:
- Characterization of potential NMDA and cholecystokinin antagonists: II. Lipophilicity studies on 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acid derivativesInternational Journal of Pharmaceutics, 1999
- Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptorsBritish Journal of Pharmacology, 1999
- Molecular Determinants of Agonist Discrimination by NMDA Receptor Subunits: Analysis of the Glutamate Binding Site on the NR2B SubunitNeuron, 1997
- Glutamate Receptor (gamma-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionate and Kainate Subtype) Activity Enhanced by Dizocilpine (MK801) in Rat Hippocampus. Rapid Chemical Kinetic Measurements of Sodium Flux and Receptor Desensitization with Native MembranesEuropean Journal of Biochemistry, 1995
- Modulation of GABA flux across rat brain membranes resolved by a rapid quenched incubation techniqueNeuroscience Letters, 1994
- Cloned Glutamate ReceptorsAnnual Review of Neuroscience, 1994
- Ibotenic Acid Analogues. Synthesis, Molecular Flexibility, and in Vitro Activity of Agonists and Antagonists at Central Glutamic Acid ReceptorsJournal of Medicinal Chemistry, 1985
- Acylanthranils. 7. Influence of the end group on selectivity in the reaction of .omega.-substituted linear aliphatic amines with acetylanthranilThe Journal of Organic Chemistry, 1978
- Determination of the equilibrium constant of hydrogen bonding between substituted h-[d]-phenols and vinyl acetate in CCl4 by i.r. measurementsSpectrochimica Acta Part A: Molecular Spectroscopy, 1976
- Relationship between CNS Depressant and Enzyme Inhibitory Properties of Substituted Quinazolone 1,3,4-OxadiazolesJournal of Pharmaceutical Sciences, 1973